Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stable indicator cell lines exhibiting HIV-1 tat function.

L T Bacheler1, L L Strehl, R H Neubauer

  • 1Medical Products Department, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19880-0400.

AIDS Research and Human Retroviruses
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical factors influencing prion inactivation by sodium hydroxide.

Vox sanguinis·2006
Same author

Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.

Biologicals : journal of the International Association of Biological Standardization·2002
Same author

Pathogen safety of manufacturing processes for biological products: special emphasis on KOGENATE Bayer.

Haemophilia : the official journal of the World Federation of Hemophilia·2002
Same author

Ensuring the pathogen safety of intravenous immunoglobulin and other human plasma-derived therapeutic proteins.

The Journal of allergy and clinical immunology·2001
Same author

Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors.

Bioorganic & medicinal chemistry letters·2001
Same author

4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

Bioorganic & medicinal chemistry letters·2001
Same journal

Identification of a Complex HIV-1 Circulating Recombinant Form (CRF203_cpx) Originating from Three Main Circulating Recombinant Forms in China.

AIDS research and human retroviruses·2026
Same journal

Near Full-Length Genome Characterization of a Novel Second-Generation HIV-1 CRF01_AE/CRF07_BC Recombinant Identified in an MSM Individual in Guizhou, China.

AIDS research and human retroviruses·2026
Same journal

Evolving Indications and Diagnostic Spectrum of Bone Marrow Examination in People with HIV During the Antiretroviral Therapy Era: A 6-Year Retrospective Study.

AIDS research and human retroviruses·2026
Same journal

A Conserved Natural Killer Cell Transcriptional Fingerprint in Rhesus Macaque Models of Acute Viral Infections.

AIDS research and human retroviruses·2026
Same journal

Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda.

AIDS research and human retroviruses·2026
Same journal

Genomic Characterization of Two Novel Human Immunodeficiency Virus-1 Recombinant Forms (CRF01_AE and B) in Men Who Have Sex with Men in Hebei, China.

AIDS research and human retroviruses·2026
See all related articles

Researchers developed a new HIV tat transactivation assay using stable cell lines. This virus-free system enables high-capacity screening of compounds to combat HIV infection.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • The human immunodeficiency virus (HIV) tat protein is crucial for viral replication and represents a key therapeutic target.
  • Developing efficient screening systems is vital for identifying novel anti-HIV compounds.

Purpose of the Study:

  • To establish a robust, virus-free cell-based assay for screening compounds that inhibit HIV tat transactivation.
  • To leverage stable cell lines for high-throughput screening of potential HIV therapeutics.

Main Methods:

  • Generation of stable human cell lines expressing beta-galactosidase under the control of the HIV-1 long terminal repeat (LTR) and tat gene.
  • Quantification of beta-galactosidase enzymatic activity using spectrophotometry in microtiter plate formats.
  • Utilizing a virus-free system for assessing tat-mediated transactivation.

Related Experiment Videos

Main Results:

  • The engineered cell lines demonstrated a 1000-fold induction of gene expression mediated by the HIV tat protein.
  • High sensitivity achieved, allowing detection from fewer than 5000 cells per well.
  • The system proved effective for rapid, spectrophotometric quantitation of enzymatic activity.

Conclusions:

  • Stable cell lines provide a reliable and efficient platform for high-capacity screening of compounds targeting HIV tat.
  • This virus-free assay facilitates the discovery of novel therapeutic interventions for HIV infection.
  • The system's sensitivity and throughput support drug discovery efforts against HIV transactivation mechanisms.